Colorectal Cancer Drugs Market Report

China Colorectal Cancer Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Sep 25, 2023
  • PAGES：191
  • REPORT CODE：GMM1813678
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • There are few available adjuvant/neoadjuvant medicines for treatment of high-risk resectable colorectal cancer. Lack of pipeline agents in this setting presents a good opportunity for development of effective treatments that can improve cure rates for resected patients.

    This report elaborates on the current development of the Colorectal Cancer Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Amgen

    • Vaccinogen

    • Hutchison MediPharma

    • Boehringer Ingelheim

    • Regeneron

    • Roch

    • Sanofi

    • Bayer

    • Mologen

    • Bristol-Myers Squibb

    • AB Science

    • Taiho Pharmaceutical

    • Elli Lilly

    By Type:

    • Immunomodulators

    • Vascular Endothelial Growth Factor (VEGF) Inhibitors

    • Tyrosine Kinase (TKI) Inhibitors

    • BRAF or MEK Inhibitors

    • Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors

    • Epidermal Growth Factor Receptor (EGFR) Inhibitors

    By Application:

    • Chemotherapy

    • Radiotherapy

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Colorectal Cancer Drugs Market Overview 2018-2029

    • 1.1 China Colorectal Cancer Drugs Industry Development Overview

    • 1.2 China Colorectal Cancer Drugs Industry Development History

    • 1.3 China Colorectal Cancer Drugs Industry Market Size (2018-2029)

    • 1.4 China Colorectal Cancer Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Colorectal Cancer Drugs Production Volume, Production Value and Growth Rate of Immunomodulators (2018-2029)

      • 1.4.2 China Colorectal Cancer Drugs Production Volume, Production Value and Growth Rate of Vascular Endothelial Growth Factor (VEGF) Inhibitors (2018-2029)

      • 1.4.3 China Colorectal Cancer Drugs Production Volume, Production Value and Growth Rate of Tyrosine Kinase (TKI) Inhibitors (2018-2029)

      • 1.4.4 China Colorectal Cancer Drugs Production Volume, Production Value and Growth Rate of BRAF or MEK Inhibitors (2018-2029)

      • 1.4.5 China Colorectal Cancer Drugs Production Volume, Production Value and Growth Rate of Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors (2018-2029)

      • 1.4.6 China Colorectal Cancer Drugs Production Volume, Production Value and Growth Rate of Epidermal Growth Factor Receptor (EGFR) Inhibitors (2018-2029)

    • 1.5 China Colorectal Cancer Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Colorectal Cancer Drugs Sales Volume, Sales Value and Growth Rate of Chemotherapy (2018-2029)

      • 1.5.2 China Colorectal Cancer Drugs Sales Volume, Sales Value and Growth Rate of Radiotherapy (2018-2029)

    • 1.6 China Colorectal Cancer Drugs Market Analysis by Region

      • 1.6.1 North China Colorectal Cancer Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Colorectal Cancer Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Colorectal Cancer Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Colorectal Cancer Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Colorectal Cancer Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Colorectal Cancer Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Colorectal Cancer Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Colorectal Cancer Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Colorectal Cancer Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Colorectal Cancer Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Colorectal Cancer Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Colorectal Cancer Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Colorectal Cancer Drugs Industry Development

    Chapter 3 Colorectal Cancer DrugsIndustry Chain Analysis

    • 3.1 Colorectal Cancer Drugs Industry Chain

    • 3.2 Colorectal Cancer Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Colorectal Cancer Drugs Market

    • 3.3 Colorectal Cancer Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Colorectal Cancer Drugs Market

    Chapter 4 China Colorectal Cancer Drugs Market, by Type

    • 4.1 China Colorectal Cancer Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Colorectal Cancer Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Colorectal Cancer Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Colorectal Cancer Drugs Production Volume and Growth Rate of Immunomodulators

      • 4.5.2 China Colorectal Cancer Drugs Production Volume and Growth Rate of Vascular Endothelial Growth Factor (VEGF) Inhibitors

      • 4.5.3 China Colorectal Cancer Drugs Production Volume and Growth Rate of Tyrosine Kinase (TKI) Inhibitors

      • 4.5.4 China Colorectal Cancer Drugs Production Volume and Growth Rate of BRAF or MEK Inhibitors

      • 4.5.5 China Colorectal Cancer Drugs Production Volume and Growth Rate of Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors

      • 4.5.6 China Colorectal Cancer Drugs Production Volume and Growth Rate of Epidermal Growth Factor Receptor (EGFR) Inhibitors

    Chapter 5 China Colorectal Cancer Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Colorectal Cancer Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Colorectal Cancer Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Colorectal Cancer Drugs Market Size and Growth Rate of Chemotherapy

      • 5.5.2 China Colorectal Cancer Drugs Market Size and Growth Rate of Radiotherapy

    Chapter 6 China Colorectal Cancer Drugs Market, by Region

    • 6.1 China Colorectal Cancer Drugs Production Volume and Production Value, by Region

    • 6.2 China Colorectal Cancer Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Colorectal Cancer Drugs Market Analysis

    • 7.1 North China Colorectal Cancer Drugs Market, by Type

    • 7.2 North China Colorectal Cancer Drugs Market, by Application

    Chapter 8 Central China Colorectal Cancer Drugs Market Analysis

    • 8.1 Central China Colorectal Cancer Drugs Market, by Type

    • 8.2 Central China Colorectal Cancer Drugs Market, by Application

    Chapter 9 South China Colorectal Cancer Drugs Market Analysis

    • 9.1 South China Colorectal Cancer Drugs Market, by Type

    • 9.2 South China Colorectal Cancer Drugs Market, by Application

    Chapter 10 East China Colorectal Cancer Drugs Market Analysis

    • 10.1 East China Colorectal Cancer Drugs Market, by Type

    • 10.2 East China Colorectal Cancer Drugs Market, by Application

    Chapter 11 Northeast China Colorectal Cancer Drugs Market Analysis

    • 11.1 Northeast China Colorectal Cancer Drugs Market, by Type

    • 11.2 Northeast China Colorectal Cancer Drugs Market, by Application

    Chapter 12 Southwest China Colorectal Cancer Drugs Market Analysis

    • 12.1 Southwest China Colorectal Cancer Drugs Market, by Type

    • 12.2 Southwest China Colorectal Cancer Drugs Market, by Application

    Chapter 13 Northwest China Colorectal Cancer Drugs Market Analysis

    • 13.1 Northwest China Colorectal Cancer Drugs Market, by Type

    • 13.2 Northwest China Colorectal Cancer Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Amgen

        • 14.1.1 Amgen Company Profile

        • 14.1.2 Amgen Colorectal Cancer Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Vaccinogen

        • 14.2.1 Vaccinogen Company Profile

        • 14.2.2 Vaccinogen Colorectal Cancer Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Hutchison MediPharma

        • 14.3.1 Hutchison MediPharma Company Profile

        • 14.3.2 Hutchison MediPharma Colorectal Cancer Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Boehringer Ingelheim

        • 14.4.1 Boehringer Ingelheim Company Profile

        • 14.4.2 Boehringer Ingelheim Colorectal Cancer Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Regeneron

        • 14.5.1 Regeneron Company Profile

        • 14.5.2 Regeneron Colorectal Cancer Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Roch

        • 14.6.1 Roch Company Profile

        • 14.6.2 Roch Colorectal Cancer Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Sanofi

        • 14.7.1 Sanofi Company Profile

        • 14.7.2 Sanofi Colorectal Cancer Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Bayer

        • 14.8.1 Bayer Company Profile

        • 14.8.2 Bayer Colorectal Cancer Drugs Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Mologen

        • 14.9.1 Mologen Company Profile

        • 14.9.2 Mologen Colorectal Cancer Drugs Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Bristol-Myers Squibb

        • 14.10.1 Bristol-Myers Squibb Company Profile

        • 14.10.2 Bristol-Myers Squibb Colorectal Cancer Drugs Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 AB Science

        • 14.11.1 AB Science Company Profile

        • 14.11.2 AB Science Colorectal Cancer Drugs Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Taiho Pharmaceutical

        • 14.12.1 Taiho Pharmaceutical Company Profile

        • 14.12.2 Taiho Pharmaceutical Colorectal Cancer Drugs Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Elli Lilly

        • 14.13.1 Elli Lilly Company Profile

        • 14.13.2 Elli Lilly Colorectal Cancer Drugs Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Colorectal Cancer Drugs Industry Research Conclusions

    • 15.2 Colorectal Cancer Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Colorectal Cancer Drugs Industry Market Size (2018-2029)

    • Figure China Colorectal Cancer Drugs Production Volume, Production Value and Growth Rate of Immunomodulators (2018-2029)

    • Figure China Colorectal Cancer Drugs Production Volume, Production Value and Growth Rate of Vascular Endothelial Growth Factor (VEGF) Inhibitors (2018-2029)

    • Figure China Colorectal Cancer Drugs Production Volume, Production Value and Growth Rate of Tyrosine Kinase (TKI) Inhibitors (2018-2029)

    • Figure China Colorectal Cancer Drugs Production Volume, Production Value and Growth Rate of BRAF or MEK Inhibitors (2018-2029)

    • Figure China Colorectal Cancer Drugs Production Volume, Production Value and Growth Rate of Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors (2018-2029)

    • Figure China Colorectal Cancer Drugs Production Volume, Production Value and Growth Rate of Epidermal Growth Factor Receptor (EGFR) Inhibitors (2018-2029)

    • Figure China Colorectal Cancer Drugs Sales Volume, Sales Value and Growth Rate of Chemotherapy (2018-2029)

    • Figure China Colorectal Cancer Drugs Sales Volume, Sales Value and Growth Rate of Radiotherapy (2018-2029)

    • Figure North China Colorectal Cancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Colorectal Cancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Colorectal Cancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Colorectal Cancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Colorectal Cancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Colorectal Cancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Colorectal Cancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure Colorectal Cancer Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Colorectal Cancer Drugs Market Share by Type in 2018

    • Figure China Colorectal Cancer Drugs Market Share by Type in 2023

    • Figure China Colorectal Cancer Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Colorectal Cancer Drugs Production Volume and Growth Rate of Immunomodulators (2018-2023)

    • Figure China Colorectal Cancer Drugs Production Volume and Growth Rate of Vascular Endothelial Growth Factor (VEGF) Inhibitors (2018-2023)

    • Figure China Colorectal Cancer Drugs Production Volume and Growth Rate of Tyrosine Kinase (TKI) Inhibitors (2018-2023)

    • Figure China Colorectal Cancer Drugs Production Volume and Growth Rate of BRAF or MEK Inhibitors (2018-2023)

    • Figure China Colorectal Cancer Drugs Production Volume and Growth Rate of Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors (2018-2023)

    • Figure China Colorectal Cancer Drugs Production Volume and Growth Rate of Epidermal Growth Factor Receptor (EGFR) Inhibitors (2018-2023)

    • Figure China Colorectal Cancer Drugs Market Share by Application in 2018

    • Figure China Colorectal Cancer Drugs Market Share by Application in 2023

    • Figure China Colorectal Cancer Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Colorectal Cancer Drugs Market Size and Growth Rate of Chemotherapy (2018-2023)

    • Figure China Colorectal Cancer Drugs Market Size and Growth Rate of Radiotherapy (2018-2023)

    • Table China Colorectal Cancer Drugs Production Volume by Region (2018-2023)

    • Table China Colorectal Cancer Drugs Production Volume Share by Region (2018-2023)

    • Figure China Colorectal Cancer Drugs Production Volume Share by Region (2018-2023)

    • Table China Colorectal Cancer Drugs Production Value by Region (2018-2023)

    • Table China Colorectal Cancer Drugs Production Value Share by Region (2018-2023)

    • Figure China Colorectal Cancer Drugs Production Value Share by Region (2018-2023)

    • Table China Colorectal Cancer Drugs Sales Volume by Region (2018-2023)

    • Table China Colorectal Cancer Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Colorectal Cancer Drugs Sales Volume Share by Region (2018-2023)

    • Table China Colorectal Cancer Drugs Sales Value by Region (2018-2023)

    • Table China Colorectal Cancer Drugs Sales Value Share by Region (2018-2023)

    • Figure China Colorectal Cancer Drugs Sales Value Share by Region (2018-2023)

    • Table North China Colorectal Cancer Drugs Production Volume by Type (2018-2023)

    • Table North China Colorectal Cancer Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Colorectal Cancer Drugs Production Volume Share by Type (2018-2023)

    • Table North China Colorectal Cancer Drugs Sales Volume by Application (2018-2023)

    • Table North China Colorectal Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Colorectal Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Colorectal Cancer Drugs Production Volume by Type (2018-2023)

    • Table Central China Colorectal Cancer Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Colorectal Cancer Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Colorectal Cancer Drugs Sales Volume by Application (2018-2023)

    • Table Central China Colorectal Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Colorectal Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Colorectal Cancer Drugs Production Volume by Type (2018-2023)

    • Table South China Colorectal Cancer Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Colorectal Cancer Drugs Production Volume Share by Type (2018-2023)

    • Table South China Colorectal Cancer Drugs Sales Volume by Application (2018-2023)

    • Table South China Colorectal Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Colorectal Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Colorectal Cancer Drugs Production Volume by Type (2018-2023)

    • Table East China Colorectal Cancer Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Colorectal Cancer Drugs Production Volume Share by Type (2018-2023)

    • Table East China Colorectal Cancer Drugs Sales Volume by Application (2018-2023)

    • Table East China Colorectal Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Colorectal Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Colorectal Cancer Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Colorectal Cancer Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Colorectal Cancer Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Colorectal Cancer Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Colorectal Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Colorectal Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Colorectal Cancer Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Colorectal Cancer Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Colorectal Cancer Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Colorectal Cancer Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Colorectal Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Colorectal Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Colorectal Cancer Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Colorectal Cancer Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Colorectal Cancer Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Colorectal Cancer Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Colorectal Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Colorectal Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Table Amgen Company Profile

    • Table Amgen Colorectal Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Vaccinogen Company Profile

    • Table Vaccinogen Colorectal Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Hutchison MediPharma Company Profile

    • Table Hutchison MediPharma Colorectal Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim Company Profile

    • Table Boehringer Ingelheim Colorectal Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Regeneron Company Profile

    • Table Regeneron Colorectal Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Roch Company Profile

    • Table Roch Colorectal Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Colorectal Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Bayer Company Profile

    • Table Bayer Colorectal Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Mologen Company Profile

    • Table Mologen Colorectal Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Profile

    • Table Bristol-Myers Squibb Colorectal Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table AB Science Company Profile

    • Table AB Science Colorectal Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Taiho Pharmaceutical Company Profile

    • Table Taiho Pharmaceutical Colorectal Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Elli Lilly Company Profile

    • Table Elli Lilly Colorectal Cancer Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US